Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Reumatologia Clinica
|
July 29, 2011
[Predictors of response to biologic therapies in rheumatoid arthritis]
Lara M Chaves Chaparro, Juan Salvatierra Ossorio, Enrique Raya Álvarez
Journal of Clinical Medicine
|
October 16, 2025
Periodontitis, Dyslipidemia and Rheumatoid Arthritis: An Additive Model of Cardiovascular Risk
Marco Bonilla, Enrique Raya-Álvarez, Manuel Bravo, et al.
Antioxidants (Basel, Switzerland)
|
August 26, 2023
Melatonin Improves Skeletal Muscle Structure and Oxidative Phenotype by Regulating Mitochondrial Dynamics and Autophagy in Zücker Diabetic Fatty Rat
Diego Salagre, Enrique Raya Álvarez, Cruz Miguel Cendan, et al.
Journal of Clinical Medicine
|
November 27, 2024
Impact of Protein Citrullination by Periodontal Pathobionts on Oral and Systemic Health: A Systematic Review of Preclinical and Clinical Studies
Marco Bonilla, Natividad Martín-Morales, Rocío Gálvez-Rueda, et al.
Odontology
|
June 13, 2025
CD11b as a diagnostic biomarker of rheumatoid arthritis and as a risk factor of periodontitis: a pilot study
Marco Bonilla, Manuel Bravo, Mahtab Moradi, et al.
Clinical and Experimental Rheumatology
|
June 7, 2013
Life-threatening vasculo-Behçet following discontinuation of infliximab after three years of complete remission
César Magro-Checa, Juan Salvatierra, José Luis Rosales-Alexander, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
March 26, 2015
An examination of the mechanisms involved in secondary clinical failure to adalimumab or etanercept in inflammatory arthropathies
Sara Bandrés Ciga, Juan Salvatierra, Mar López-Sidro, et al.
Joint Bone Spine
|
August 13, 2013
Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors
José Luis Rosales Alexander, Jesús Cantero-Hinojosa, Juan Salvatierra, et al.
Acta Dermato-Venereologica
|
September 3, 2013
Association of 25-hydroxyvitamin D with metabolic syndrome in patients with psoriasis: a case-control study
Jacinto Orgaz-Molina, César Magro-Checa, Miguel A Arrabal-Polo, et al.
Reumatologia Clinica
|
July 29, 2011
[The impact of therapy with TNF-blockers on health-related quality of life in rheumatoid arthritis patients. A pilot study]
Gracia María Abalos Medina, Gonzalo Ruiz Villaverde, Daniel Sánchez Cano, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Reumatologia Clinica
|
July 29, 2011
[Predictors of response to biologic therapies in rheumatoid arthritis]
Lara M Chaves Chaparro, Juan Salvatierra Ossorio, Enrique Raya Álvarez
Journal of Clinical Medicine
|
October 16, 2025
Periodontitis, Dyslipidemia and Rheumatoid Arthritis: An Additive Model of Cardiovascular Risk
Marco Bonilla, Enrique Raya-Álvarez, Manuel Bravo, et al.
Antioxidants (Basel, Switzerland)
|
August 26, 2023
Melatonin Improves Skeletal Muscle Structure and Oxidative Phenotype by Regulating Mitochondrial Dynamics and Autophagy in Zücker Diabetic Fatty Rat
Diego Salagre, Enrique Raya Álvarez, Cruz Miguel Cendan, et al.
Journal of Clinical Medicine
|
November 27, 2024
Impact of Protein Citrullination by Periodontal Pathobionts on Oral and Systemic Health: A Systematic Review of Preclinical and Clinical Studies
Marco Bonilla, Natividad Martín-Morales, Rocío Gálvez-Rueda, et al.
Odontology
|
June 13, 2025
CD11b as a diagnostic biomarker of rheumatoid arthritis and as a risk factor of periodontitis: a pilot study
Marco Bonilla, Manuel Bravo, Mahtab Moradi, et al.
Clinical and Experimental Rheumatology
|
June 7, 2013
Life-threatening vasculo-Behçet following discontinuation of infliximab after three years of complete remission
César Magro-Checa, Juan Salvatierra, José Luis Rosales-Alexander, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
March 26, 2015
An examination of the mechanisms involved in secondary clinical failure to adalimumab or etanercept in inflammatory arthropathies
Sara Bandrés Ciga, Juan Salvatierra, Mar López-Sidro, et al.
Joint Bone Spine
|
August 13, 2013
Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors
José Luis Rosales Alexander, Jesús Cantero-Hinojosa, Juan Salvatierra, et al.
Acta Dermato-Venereologica
|
September 3, 2013
Association of 25-hydroxyvitamin D with metabolic syndrome in patients with psoriasis: a case-control study
Jacinto Orgaz-Molina, César Magro-Checa, Miguel A Arrabal-Polo, et al.
Reumatologia Clinica
|
July 29, 2011
[The impact of therapy with TNF-blockers on health-related quality of life in rheumatoid arthritis patients. A pilot study]
Gracia María Abalos Medina, Gonzalo Ruiz Villaverde, Daniel Sánchez Cano, et al.
Page
of 3